- CohBar (NASDAQ:CWBR) announces a proposed underwritten public offering of units consisting of one common share and one warrant to purchase 0.75 of a share within 5 years. Price, terms and volume not yet disclosed.
- Underwriters' overallotment option is additional 15% of units offered.
- CohBar intends to use the net proceeds for general corporate purposes, including funding preclinical and clinical development of its peptides.
- Previously: CohBar files for $100M mixed shelf (Aug. 24)